… many inflammatory … inflammatory diseases, IL-1 and TNF- are the important cytokines that
can induce the expression of NF-B which is the potential target in these inflammatory diseases. …

… population of patients the more affected by inflammatory diseases. Rheumatoid arthritis (RA)
is a chronic, systemic inflammatory disease treated with high doses of glucocorticoids. To …

… such as developmental abnormalities, cancer, and autoimmune diseases (… -inflammatory
agents, and their potential utility as novel therapeutics for the treatment of inflammatory diseases…

… drug ready for treatment of diseases in acute … for inflammatory diseases. Several phase III
clinical trials for treatment of acute Graft Versus Host Disease (GVHD) and Crohn’s disease are …

… Therefore anti-inflammatory therapy is a very promising strategy for the prevention …
treatment of these inflammatory diseases. To overcome the shortcomings of existing anti-inflammatory …

… treatment algorithms for IBD in the last 15 years, but primarily and more importantly secondary
loss of response is often observed. Fortunately , new treatment … for new treatment options …

… disease. This review focuses on the current treatments for inflammatory bowel disease.
Keywords: inflammatory bowel disease (lED), 5-aminosalicylates, cOliicosteroids, infliximab …

… target for treatment of RA, while we will also illustrate the potential problems of inhibiting
NF-κB for the treatment of septic shock. A well studied paradigm for chronic inflammation is RA, …

… treatment. Recent advances in the management of IBD have led to a paradigm shift in the
treatment … In this review, the latest progress in IBD treatment is summarized to understand the …

… , although human inflammatory cell activity … treatment of a range of inflammatory diseases,
including asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease…